Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)
China flag China · Delayed Price · Currency is CNY
19.61
+0.06 (0.31%)
Sep 4, 2026, 3:00 PM CST

SHA:600285 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
743.7382.841,2281,4991,179801.24
Short-Term Investments
692.26547.59283.0195.63125.34140.77
Trading Asset Securities
130.31160.35-0.21150.42280.19
Cash & Short-Term Investments
1,5661,0911,5111,5951,4551,222
Cash Growth
38.36%-27.83%-5.23%9.60%19.05%47.32%
Accounts Receivable
877.28713.34488.95498.99511.97431.18
Other Receivables
14.377.16.2919.3521.379.58
Receivables
891.65720.44495.23518.34533.34440.77
Inventory
359.1436.64434.97467.35486.41428.39
Other Current Assets
20.932.0216.4518.5133.5839.87
Total Current Assets
2,8382,2802,4582,5992,5082,131
Property, Plant & Equipment
707.15682.62631.2647.81706.76732.92
Long-Term Investments
1,1251,5701,4371,069676.63364.7
Goodwill
482.02482.02----
Other Intangible Assets
343.38330.14203.75202.5203.65236.95
Long-Term Deferred Tax Assets
230.41198.35199.59186.92159.2116.49
Long-Term Deferred Charges
20.1118.5412.3436.7351.5465.53
Other Long-Term Assets
9.4473.4874.4529.9838.45145.25
Total Assets
5,7565,6365,0174,7724,3453,793

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
92.197.2785.1357.3868.0278.01
Accrued Expenses
1,3871,1211,1761,110917.79600.38
Short-Term Debt
415.2409.5290.47199.94151.15272.34
Current Portion of Leases
1.942.591.781.081.221.65
Current Income Taxes Payable
106.2949.8156.2870.7255.5446.9
Current Unearned Revenue
66.883.64114.28114.48153.7579.09
Other Current Liabilities
338.72352.12350.24346.95364.47359.28
Total Current Liabilities
2,4082,1161,8741,9001,7121,438
Long-Term Leases
3.554.276.556.966.27.9
Long-Term Unearned Revenue
35.383133.439.7838.5542.78
Long-Term Deferred Tax Liabilities
3948.7422.2726.3229.5618.18
Total Liabilities
2,4862,2001,9371,9731,7861,507

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
567.12567.12567.12567.14567.46567.76
Additional Paid-In Capital
371.04367.2340.61326.23309.82272.02
Retained Earnings
2,3102,4382,1811,8941,6641,481
Treasury Stock
-5.6-12.58-13.7-47.4-67.62-98.19
Comprehensive Income & Other
-10.6240.41-2.025176.7456.08
Total Common Equity
3,2323,4013,0732,7912,5512,279
Minority Interest
38.1235.337.777.667.557.59
Shareholders' Equity
3,2703,4363,0802,7992,5582,287
Total Liabilities & Equity
5,7565,6365,0174,7724,3453,793

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
420.68416.3898.8207.99158.57281.89
Net Cash (Debt)
1,146674.411,4131,3871,296940.31
Net Cash Growth
87.59%-52.26%1.86%6.96%37.88%41.69%
Net Cash Per Share
2.021.192.502.452.281.66
Filing Date Shares Outstanding
567.12566.13564.42563.94569.61564.55
Total Common Shares Outstanding
567.12566.13564.42563.94569.61564.55
Working Capital
429.99164.31583.7698.77796.44693.59
Book Value Per Share
5.706.015.444.954.484.04
Tangible Book Value
2,4062,5882,8692,5892,3472,042
Tangible Book Value Per Share
4.244.575.084.594.123.62
Buildings
656.69659.16588.03593.96595.01582.83
Machinery
677.92672.16591.9581.63581.92534.7
Construction In Progress
65.0116.0134.22.881.9224.78